A Long-Term, Single-Arm, Open-label, Multicenter Phase 3 Study to Evaluate the Safety and Tolerability of Multiple Subcutaneous Injections of Efgartigimod PH20 SC in Patients With Generalized Myasthenia Gravis
Lay Description
Category
- IRB Number
- 20210337HU
- NCT Number
- NCT # not yet entered
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Carolyn Paiz
210-450-8830
paizc@uthscsa.edu
Sarah Martinez
210-450-0569
martinezs23@uthscsa.edu
Charlotte Rhodes
210-450-8454
rhodesc1@uthscsa.edu
Principal Investigator
Ratna Bhavaraju-Sanka